Imexpharm earns 102.7b dong pre-tax profit in 11-months

16-Dec-2011 Intellasia | Vietbiz24 | 7:01 AM Print This Post

Listed firm Imexpharm Joint Stock Co (IMP) reported gaining total revenues at 57.6 billion dong in November, lifting the figure of the first 11 months of 2011 to 661 billion dong, meeting 82.6 percent of the year’s plan.

Its pre-tax profit reached 8.4 billion dong in November alone and 102.7 billion dong in the Jan-November period.

Till this time, IMP has surpassed 2.7 percent of 2011 target.

 


Category: Business

Print This Post

Comments are closed.